Report Highlights
Metagenomic Sequencing Market Size And Forecast
Metagenomic Sequencing Market was valued at USD 421.49 Million in 2018 and is projected to reach USD 675.83 Million by 2026, growing at a CAGR of 6.05% from 2019 to 2026.
Global Metagenomic Sequencing Market Overview
The development of Next Generation DNA Sequencing (NGS) technology has considerably shaped molecular biology research, which has led to several discoveries and new insights. Next-generation DNA sequencing technology goes beyond long-established DNA sequencing with its applications that reach across the principles of molecular biology. Thus, it can be stated that the rise in technological advancements regarding DNA sequencing will drive the market.
Global Metagenomic Sequencing Market: Segmentation
The Metagenomic Sequencing market is segmented on the basis of workflow, product & services, technology, application, and geography.
The major players in the market are Illumina, Thermo Fisher Scientific, Pacific Biosciences of California Qiagen, BGI, Perkinelmer and Oxford Nanopore Technologies.
Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More